Quince Therapeutics, Inc. - COM (QNCX)

Historical Portfolio Holders from Q2 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
5.19M
Holdings value Q3 2024
$4.04M
Value change Q3 2024
-$768K
Grand Portfolio weight change Q3 2024
0%
Number of holders
32
Number of buys Q3 2024
13
Number of sells Q3 2024
-14
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 5.19M $4.04M -$768K $0.78 32
2024 Q2 6.24M $4.67M -$801K $0.75 40
2024 Q1 7.25M $7.69M -$189K $1.06 42
2023 Q4 7.43M $7.8M -$54.1K $1.05 39
2023 Q3 7.48M $8.38M -$2.28M $1.12 39
2023 Q2 8.95M $13.5M +$1.95M $1.51 39
2023 Q1 7.66M $11.9M +$3.81M $1.56 42
2022 Q4 5.39M $3.43M -$3.31M $0.64 45
2022 Q3 9.31M $12.4M -$3.93M $1.33 52
2022 Q2 11.7M $26M -$20.3M $2.22 62
2022 Q1 14.2M $88.1M -$45.9M $6.19 87
2021 Q4 19.2M $243M -$220M $12.62 100
2021 Q3 19.2M $1.76B +$80.9M $91.66 135
2021 Q2 18.5M $983M -$6.1M $53.00 111
2021 Q1 18.7M $673M +$37M $36.03 93
2020 Q4 17.7M $491M +$26.8M $27.78 86
2020 Q3 16.5M $827M +$55.3M $50.00 86
2020 Q2 15.4M $715M +$185M $46.30 82
2020 Q1 11.5M $523M +$39.6M $45.61 65
2019 Q4 10.6M $594M +$91.9M $56.14 51
2019 Q3 5.85M $145M +$81.3M $24.93 41
2019 Q2 2.42M $103M +$103M $42.51 37